Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Update on Possible Offer

17 Apr 2007 07:01

Calyx Group PLC17 April 2007 Calyx Group plc ("Calyx" or the "Company") Update on Possible Offer Calyx announced on 13 March 2007 that it had received a preliminary approachfrom Maurice Healy and certain members of the Company's senior management team(the "Potential Offeror") that may or may not lead to an offer for the Company.An independent sub-committee of the Board, consisting of the Company'snon-executive directors Gary Kennedy, Neil Parkinson and Nicholas Koumarianos(the "Committee"), was formed to consider the approach and has retained DavyCorporate Finance to act as financial adviser. The Committee has been advised by the Potential Offeror that certain financialand commercial due diligence on the Company has now been prepared and thatnegotiations with potential providers of equity and debt funding are ongoing. It is the intention of the Committee to ascertain in a timely manner whetherthis or any other expression of interest that may be received can be translatedinto a firm proposal capable of being recommended to shareholders. The Committee will update shareholders in relation to these matters in duecourse. Enquiries: Calyx Group plc +353 1 676 3363Gary Kennedy Davy +353 1 679 6363Ronan GodfreyJohn Frain The Directors of the Company accept responsibility for the information containedin this announcement. To the best of the knowledge and belief of the Directorsof the Company (who have taken all reasonable care to ensure such is the case)the information contained in this announcement is in accordance with the factsand does not omit anything likely to affect the import of such information. Davy Corporate Finance Limited, which is regulated in Ireland by the FinancialRegulator, is acting for the Company and no-one else in relation to the Approachand will not be responsible to anyone other than the Company for providingadvice in relation to the Approach. Any person who is the holder of 1 per cent or more of any class of shares in theCompany may be required to make disclosures pursuant to Rule 8.3 of the IrishTakeover Panel Act 1997, Takeover Rules 2001 to 2005. 17 April 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th May 20237:00 amRNSNotice of Results and Investor Presentation
14th Apr 20236:03 pmRNSPDMR Dealings
14th Apr 20233:24 pmRNSDirector Dealing
15th Mar 20231:15 pmRNSDirector Dealings
14th Mar 20234:00 pmRNSPDMR Dealings
7th Mar 20239:05 amRNSSecond Price Monitoring Extn
7th Mar 20239:00 amRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSTrading Update
15th Feb 202310:59 amRNSPDMR Dealings
19th Jan 20239:56 amRNSPDMR Dealings
17th Jan 20239:56 amRNSDirector / PDMR Dealings
17th Jan 20239:52 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSBoard Changes
13th Jan 20234:00 pmRNSDirector/PDMR Dealing
13th Dec 20222:15 pmRNSDirector / PDMR Dealings
22nd Nov 20227:00 amRNSInterim Results
21st Nov 20225:43 pmRNSDirector / PDMR Dealings
27th Oct 20227:00 amRNSNotice of Results and Investor Presentation
14th Oct 20223:53 pmRNSDirector/PDMR Shareholding
12th Oct 20221:29 pmRNSDirector / PDMR Dealings
15th Sep 20227:30 amRNSDirector/PDMR Dealing
17th Aug 20225:26 pmRNSResult of AGM
17th Aug 20227:00 amRNSAGM Statement
15th Aug 202210:26 amRNSDirector / PDMR Dealings
26th Jul 20223:33 pmRNSDirector / PDMR Shareholding
18th Jul 20227:00 amRNSNotice of AGM
14th Jul 20225:49 pmRNSDirector/PDMR Dealings
8th Jul 20226:01 pmRNSDirector / PDMR dealings
15th Jun 20227:00 amRNSExercise of Options
14th Jun 20227:00 amRNSBoard Update
6th Jun 20221:30 pmRNSDirector Dealing
24th May 20227:00 amRNSFY22 Final Results
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.